• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌中纤连蛋白模式及其临床意义。

Fibronectin patterns in hepatocellular carcinoma and its clinical significance.

作者信息

Jagirdar J, Ishak K G, Colombo M, Brambilla C, Paronetto F

出版信息

Cancer. 1985 Oct 1;56(7):1643-8. doi: 10.1002/1097-0142(19851001)56:7<1643::aid-cncr2820560730>3.0.co;2-o.

DOI:10.1002/1097-0142(19851001)56:7<1643::aid-cncr2820560730>3.0.co;2-o
PMID:2411380
Abstract

Fibronectin, a high molecular weight glycoprotein component of the extracellular matrix, was localized extracellularly and intracellularly in the nuclei and the cytoplasm of hepatocellular carcinomas (HCC) by the use of the biotin-avidin method on paraffin-embedded, pepsin-treated tissue. The specificity of the staining was confirmed by absorbing the antibodies with purified fibronectin. Twenty HCC were investigated (7 were autopsy specimens and 13 biopsy and surgical specimens). The fibronectin was either increased or decreased. When increased the fibronectin consisted of thin or thick feathery strands and was either pericellular, sinusoidal, periglandular, or stromal. Marked increase of fibronectin was seen in fibrolamellar HCC, clear cell HCC, and encapsulated HCC, correlating with the better prognosis. Decreased fibronectin was seen in two undifferentiated HCC. HCC obtained at autopsy displayed nuclear and cytoplasmic fibronectin staining. Nuclear fibronectin may be an expression of the DNA binding ability of fibronectin which becomes demonstrable in cells with increased membrane permeability.

摘要

纤连蛋白是细胞外基质的一种高分子量糖蛋白成分,通过对石蜡包埋、胃蛋白酶处理的组织采用生物素-抗生物素蛋白法,在肝细胞癌(HCC)的细胞核和细胞质内及细胞外均检测到其存在。用纯化的纤连蛋白吸收抗体,证实了染色的特异性。对20例HCC进行了研究(7例为尸检标本,13例为活检和手术标本)。纤连蛋白含量有增加或减少的情况。当纤连蛋白增加时,它由细或粗的羽毛状条索组成,位于细胞周围、窦状隙、腺泡周围或间质中。在纤维板层型HCC、透明细胞HCC和包膜型HCC中可见纤连蛋白显著增加,这与较好的预后相关。在2例未分化HCC中纤连蛋白减少。尸检获得的HCC显示有细胞核和细胞质纤连蛋白染色。细胞核纤连蛋白可能是纤连蛋白DNA结合能力的一种表现,在膜通透性增加的细胞中可显现出来。

相似文献

1
Fibronectin patterns in hepatocellular carcinoma and its clinical significance.肝细胞癌中纤连蛋白模式及其临床意义。
Cancer. 1985 Oct 1;56(7):1643-8. doi: 10.1002/1097-0142(19851001)56:7<1643::aid-cncr2820560730>3.0.co;2-o.
2
Fibronectin in human hepatocellular carcinoma.人肝细胞癌中的纤连蛋白
Tohoku J Exp Med. 1982 Dec;138(4):441-2. doi: 10.1620/tjem.138.441.
3
Fibronectin in human hepatocellular carcinoma (HCC) and HCC cell lines.人肝细胞癌(HCC)及HCC细胞系中的纤连蛋白
Acta Pathol Jpn. 1987 Mar;37(3):413-23. doi: 10.1111/j.1440-1827.1987.tb00375.x.
4
Immunohistochemical study of fibronectin, lysozyme, and alpha-fetoprotein (AFP) in human hepatocellular carcinoma.人肝细胞癌中纤连蛋白、溶菌酶和甲胎蛋白(AFP)的免疫组织化学研究
Gastroenterol Jpn. 1987 Feb;22(1):44-54. doi: 10.1007/BF02806334.
5
Hepatocellular carcinomas show abnormal expression of fibronectin protein.肝细胞癌显示纤连蛋白蛋白的异常表达。
Mod Pathol. 2002 Aug;15(8):826-30. doi: 10.1097/01.MP.0000024257.83046.7C.
6
Copper and copper-binding protein in fibrolamellar liver cell carcinoma.
Cancer. 1983 Jan 1;51(1):97-100. doi: 10.1002/1097-0142(19830101)51:1<97::aid-cncr2820510120>3.0.co;2-1.
7
Pattern of fibronectin in hepatocellular carcinoma and its significance.肝细胞癌中纤连蛋白的模式及其意义。
Indian J Pathol Microbiol. 2006 Jul;49(3):362-4.
8
Effects of the tumor promoter teleocidin on human hepatoma cells in tissue culture.肿瘤启动子teleocidin对组织培养中的人肝癌细胞的影响。
Gan. 1982 Aug;73(4):534-8.
9
Expression of fibronectin and laminin in the rat liver after partial hepatectomy, during carcinogenesis, and in transplantable hepatocellular carcinomas.部分肝切除术后、致癌过程中以及可移植性肝细胞癌中大鼠肝脏中纤连蛋白和层粘连蛋白的表达。
J Natl Cancer Inst. 1982 Nov;69(5):1105-14.
10
Distribution pattern of liver matrix proteins, fibronectin and type I collagen, in DAB-induced hepatoma of rat.
Tohoku J Exp Med. 1985 Aug;146(4):405-17. doi: 10.1620/tjem.146.405.

引用本文的文献

1
Membranous Overexpression of Fibronectin Predicts Microvascular Invasion and Poor Survival Outcomes in Patients with Hepatocellular Carcinoma.纤连蛋白的膜性过表达可预测肝细胞癌患者的微血管侵犯及不良生存结局。
Gut Liver. 2025 Mar 15;19(2):275-285. doi: 10.5009/gnl240254. Epub 2025 Jan 8.
2
Differential alternative splicing between hepatocellular carcinoma with normal and elevated serum alpha-fetoprotein.肝癌患者血清甲胎蛋白正常和升高时的差异选择性剪接。
BMC Med Genomics. 2020 Dec 28;13(Suppl 11):194. doi: 10.1186/s12920-020-00836-4.
3
Changes in serum fibronectin levels predict tumor recurrence in patients with early hepatocellular carcinoma after curative treatment.
血清纤连蛋白水平的变化可预测根治性治疗后早期肝细胞癌患者的肿瘤复发。
Sci Rep. 2020 Dec 4;10(1):21313. doi: 10.1038/s41598-020-78440-w.
4
Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers.肝癌血管侵犯的基因组分析揭示了分子驱动因素和预测性生物标志物。
Hepatology. 2021 Jun;73(6):2342-2360. doi: 10.1002/hep.31614. Epub 2021 May 8.
5
Fibronectin in Cancer: Friend or Foe.纤维连接蛋白在癌症中的作用:是敌是友?
Cells. 2019 Dec 20;9(1):27. doi: 10.3390/cells9010027.
6
Serum fibronectin distinguishes the early stages of hepatocellular carcinoma.血清纤维连接蛋白可区分肝细胞癌的早期阶段。
Sci Rep. 2017 Aug 25;7(1):9449. doi: 10.1038/s41598-017-09691-3.
7
Transcriptomic characterization of fibrolamellar hepatocellular carcinoma.纤维板层型肝细胞癌的转录组学特征分析
Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):E5916-25. doi: 10.1073/pnas.1424894112. Epub 2015 Oct 21.
8
A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma.一种用于鉴定肝细胞癌潜在生物标志物的定量蛋白质组学方法。
J Proteome Res. 2008 Oct;7(10):4289-98. doi: 10.1021/pr800197z. Epub 2008 Aug 21.
9
Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrix.凝血酶原对正常肝细胞的生长抑制作用:基质的影响。
Cell Biol Int. 2007 Sep;31(9):929-38. doi: 10.1016/j.cellbi.2007.03.001. Epub 2007 Mar 19.
10
Immunohistochemical study of fibronectin, lysozyme, and alpha-fetoprotein (AFP) in human hepatocellular carcinoma.人肝细胞癌中纤连蛋白、溶菌酶和甲胎蛋白(AFP)的免疫组织化学研究
Gastroenterol Jpn. 1987 Feb;22(1):44-54. doi: 10.1007/BF02806334.